Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagen vs Biodentine Pulpotomy in Primary Molars
NCT05479877Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Sep 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of Biofil-AB in reversible pulpitis (2 arms), sponsored by Cairo University. Primary endpoint: Absence of internal root resorption at 12 months. Status: unknown.
02
Drugs
Biofil-AB
03
Conditions
reversible pulpitis
Beyond the preview
Go deeper on NCT05479877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05479877.